10-Q: Q3 2024 Earnings Report

SECNov 6 17:08 ET · Announcements

SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update

GlobeNewswireNov 6 17:05 ET

SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference

GlobeNewswireSep 13 07:00 ET

Express News | SAB Biotherapeutics Inc - SAB-142 on Track for Topline Phase 1 Data Readout by Year-End

ReutersSep 9 07:01 ET

SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting

GlobeNewswireSep 9 07:00 ET

Express News | SAB Bio Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting

ReutersSep 9 07:00 ET